Article

Staging of Lymphocytic Lymphoma

Authors: JOHN M. SEXAUER MD, JOHN A. PENNER MD, RONALD H. NISHIYANMA MD

Abstract

AbstractA retrospective study of 76 cases of lymphocytic lymphomas was made to evaluate factors affecting survival. All patients were staged according to the Ann Arbor classification for Hodgkin's disease. Symptomatic patients (stage II B, III B, IV B) had a one-year survival rate of 16%. None were alive at three years. The rate of survival in asymptomatic patients (stages II A, III A, IV A) was 88% at one year and 60% at three years. Bone marrow involvement, when present, did not alter this pattern of survival and was not a factor in determining prognosis. It was concluded that the presence of systemic symptoms represents one of the most important factors in determining prognosis in lymphocytic lymphomas, and that the reliance on marrow involvement as a means of identifying end-stage disease should be de-emphasized.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References